Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies 
Trump Orders DOJ Investigation Into Exxon, Chevron Over High Gas Prices 
RFK Jr. Orders Extended Hantavirus Quarantine for Cruise Passenger 
Neuralink Expands Brain Implant Trials with 12 Global Patients 
White House Seeks $1.4 Billion to Combat Growing Ebola Outbreak 
China Expands Export Controls, Adds 20 Japanese Companies to Restricted List 
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review 
Kioxia Targets U.S. Listing as AI Chip Boom Accelerates 
Johns Hopkins University Lays Off 110 Employees as Federal Research Funding Declines 
Javier Milei Cabinet Chief Manuel Adorni Resigns Amid Spending Scandal Investigation 
Despite its best efforts, Iran won’t be able to toll the Strait of Hormuz. Here’s why 
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak 
US Strikes Iran Again After Strait of Hormuz Tanker Attack Escalates Ceasefire Tensions 
Mexico, U.S. Launch Sterile Fly Facility to Combat New World Screwworm Outbreak 
OpenAI May Delay IPO to 2027 Amid $1 Trillion Valuation Goal 
Andy Burnham Sets Out Vision to Decentralize Britain as Labour Leadership Race Begins 
Tabletop particle accelerator could transform medicine and materials science 
U.S. President Donald Trump has signed an executive order aimed at expanding the use of artificial intelligence (AI) in pediatric cancer research. The order provides an additional $50 million in research grants to accelerate progress in finding cures for childhood cancers, according to White House officials.
This move builds on the National Cancer Institute’s (NCI) Childhood Cancer Data Initiative, a decade-long, $500 million program launched in 2019 to collect and share vital data on pediatric cancers. Michael Kratsios, director of the White House Office of Science and Technology Policy, highlighted that childhood cancer remains the leading cause of disease-related deaths among children in the United States, with cases rising more than 40% since 1975.
Kratsios noted that advances in AI can now be harnessed to sharpen diagnoses, improve clinical trials, fine-tune treatment strategies, and enhance prevention methods. Data gathered through the NCI initiative is expected to empower researchers with new tools to tackle the complexity and diversity of pediatric cancers.
In addition to the $50 million in grants, the National Institutes of Health (NIH) will double its commitment by investing another $50 million. This funding aims to attract leading scientific teams through competitive research opportunities. Further investments are also anticipated to strengthen ongoing initiatives.
The announcement comes despite Trump’s 2026 budget proposal, which suggested a 37% cut to the NCI budget. Lawmakers in both the House and Senate, however, have pushed back against these cuts, and budget negotiations remain ongoing.
Globally, the World Health Organization reports that around 400,000 children and adolescents are diagnosed with cancer each year. While advances in adult cancer research have surged with AI, pediatric cancer research has lagged due to challenges like cancer rarity, diversity, and ethical concerns over patient data protection.
By reinforcing funding and leveraging AI, the administration aims to close this gap and accelerate life-saving innovations in childhood cancer treatment.
